These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2564832)

  • 1. Are antacids cytoprotective?
    Hollander D; Tarnawski A
    Gut; 1989 Feb; 30(2):145-7. PubMed ID: 2564832
    [No Abstract]   [Full Text] [Related]  

  • 2. Gastric ulcers: investigations and treatment.
    Lane MR; Lee SP
    Compr Ther; 1984 Dec; 10(12):24-31. PubMed ID: 6151443
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of Polish antacids on prostaglandin E2 values in gastric mucosa].
    Mach T; Basista M; Bogdał J; Kostka-Trabka E
    Pol Tyg Lek; 1991 Nov 11-25; 46(45-47):892-5. PubMed ID: 1669463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the transmural electric potential difference in the region of stomach ulcer. Local effect of sucralfate, aluminum hydroxide and magnesium trisilicate].
    Möckel W; Hausding P
    Fortschr Med; 1984 Jul; 102(25-26):709-12. PubMed ID: 6547921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antacids in gastric ulcer treatment: evidence of cytoprotection.
    Gasbarrini G; Andreone P; Baraldini M; Cursaro C; Micaletti E
    Scand J Gastroenterol Suppl; 1990; 174():44-7. PubMed ID: 2205899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic approach to ulcer healing.
    Blum AL
    Am J Med; 1985 Aug; 79(2C):8-14. PubMed ID: 2863981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)].
    Scheen AJ
    Rev Med Liege; 1998 Jan; 53(1):41-4. PubMed ID: 9555183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative dynamic study of the effectiveness of gastric cytoprotection by vitamin A, De-Nol, sucralfate and ulcer healing by pirenzepine in patients with chronic gastric ulcer (a multiclinical and randomized study).
    Patty I; Tárnok F; Simon L; Jávor T; Deák G; Benedek S; Kenéz P; Nagy L; Mózsik G
    Acta Physiol Hung; 1984; 64(3-4):379-84. PubMed ID: 6397969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization.
    Driks MR; Craven DE; Celli BR; Manning M; Burke RA; Garvin GM; Kunches LM; Farber HW; Wedel SA; McCabe WR
    N Engl J Med; 1987 Nov; 317(22):1376-82. PubMed ID: 2891032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptic ulcer disease: physiology and pathophysiology.
    Holt KM; Isenberg JI
    Hosp Pract (Off Ed); 1985 Jan; 20(1):89-93, 96-101, 104-6. PubMed ID: 2856923
    [No Abstract]   [Full Text] [Related]  

  • 11. Mucosal protective agents in the long-term management of gastric ulcer.
    Marks IN; Boyd E
    Med J Aust; 1985 Feb; 142 Spec No():S23-5. PubMed ID: 3841579
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antibacterial treatment of gastric ulcers associated with Helicobacter pylori without acid suppression].
    Folwaczny C
    Z Gastroenterol; 1995 Jul; 33(7):416-7. PubMed ID: 7571762
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-steroidal anti-inflammatory drug gastropathy: clinical results with antacids and sucralfate.
    Lazzaroni M; Sainaghi M; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S48-53. PubMed ID: 10379470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evidence of the cytoprotective action of antacids. Behavior of the transmural stomach electric potential difference with antacids in healthy subjects and stomach ulcer patients].
    Tympner F
    Fortschr Med; 1985 Sep; 103(33):795-8. PubMed ID: 4054802
    [No Abstract]   [Full Text] [Related]  

  • 15. Short-term treatment of gastric ulcer. A meta-analytical evaluation of blind trials.
    Di Mario F; Battaglia G; Leandro G; Grasso G; Vianello F; Vigneri S
    Dig Dis Sci; 1996 Jun; 41(6):1108-31. PubMed ID: 8654142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoprotective agents and C. pylori associated acid peptic diseases.
    Andersen LP
    Scand J Gastroenterol Suppl; 1988; 142():110-3. PubMed ID: 2901785
    [No Abstract]   [Full Text] [Related]  

  • 17. [Conservative treatment of gastric ulcer].
    Lux G; Rösch W
    Med Klin; 1980 Aug; 75(18):638-44. PubMed ID: 6106882
    [No Abstract]   [Full Text] [Related]  

  • 18. Systematic review: Antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia.
    Moayyedi P; Soo S; Deeks J; Forman D; Harris A; Innes M; Delaney B
    Aliment Pharmacol Ther; 2003 May; 17(10):1215-27. PubMed ID: 12755835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of the treatment of peptic ulcer disease.
    Bertaccini G; Coruzzi G
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):43S-51S. PubMed ID: 2865092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why do ulcers heal with sucralfate?
    Lam SK
    Scand J Gastroenterol Suppl; 1990; 173():6-16. PubMed ID: 2190306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.